
Opinion|Videos|May 8, 2024
Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma
Ke Ning, MD, discusses the impact of the introduction of bispecific antibodies for treating patients with relapsed or refractory multiple myeloma.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
2
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
3
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
4
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
5














































































































































































































